. Marketing-authorisation-holders, GlaxoSmithKline Biologicals; Merck Sharp & Dohme Limited; Sanofi Pasteur MSD 30 Churchill Place ? Canary Wharf ? London E14 5EU ? United Kingdom

©. European and M. Agency, Reproduction is authorised provided the source is acknowledged, 2015.

. Disponible-sur, html (12) Wikipédia, Commission européenne [en ligne]. Wikipédia, Mars 2016, Disponibilité et accès : https://fr.wikipedia.org/wiki/Commission_europ%C3%A9enne (13) Commission européenne, 2016.

. Commission, Commission européenne, À propos de la Commission européenne [en ligne] Commission européenne, décembre 2015. [Page consultée le 3 Février 2016] Disponibilité et accès : http://ec.europa.eu/about/index_fr.htm (15) European Commission, Health and consumers directorate-general, Rules of procedure for the standing committee on medicinal products for human use [en ligne]. Commission européenne, septembre 2011 (16) European Medicines Agency, Questions and answers: Article 31 pharmacovigilance referral, European Medicines Agency, Mars 2015. [consulté le 8 Février 2016]. Disponibilité et accès, p.76, 2015.

. Disponible-sur, Intravenous_iron- containing_medicinal_products/human_referral_000343.jsp&mid=WC0b01ac05805c516f (21) European Medicines Agency, Annex I -List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the Member States, ) European Medicines Agency, Annex IV -Conditions to the marketing authorisations

A. European-medicines, Disponible sur?curl=pages/medicines/human/referrals/Intravenous_iron- containing_medicinal_products/human_referral_000343.jsp&mid=WC0b01ac05805c516f (23) European Medicines Agency, Annex III -Amendments to relevant sections of the summary of product characteristics and package leaflets, European Medicines Agency, Novembre 2013. [consulté le 8 Mars 2016]. Disponible sur) European Medicines Agency, Annex II -Scientific conclusions and grounds for variation to the terms of the marketing authorisations [en ligne]. European Medicines Agency, 2013.

. Passeportsanté and L. Montgomery, Syndrome douloureux régional complexe [en ligne]. L'Association québécoise de la douleur chronique (AQDC), Juin Disponibilité et accès : http://www.douleurchronique.org/content_new.asp?node=189 (30) European Medicines Agency, Assessment report -Review under Article 20 of Regulation (EC) No 726/2004 -Human papillomavirus (HPV) vaccines [en ligne]. European Medicines Agency, Disponible sur Disponible sur, p.78, 2006.

. Disponible-sur, Tetrazepam_containing _medicinal_products/human_referral_prac_000015.jsp&mid=WC0b01ac05805c516f (35) European Medicines Agency, Timetable for the procedure -Procedure under article 107i of DirectiveEC -Tetrazepam containing medicinal products Disponible sur : http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Tetrazepam_containing _medicinal_products/human_referral_prac_000015.jsp&mid=WC0b01ac05805c516f (36) European Medicines Agency, Assessment report for tetrazepam containing medicinal products, European Medicines Agency, Janvier 2013. [consulté 16 Avril 2016]) European Medicines Agency, Annex III -Conditions for lifting the suspension of the marketing authorisations [en ligne]. European Medicines Agency Disponible sur, 2001.